Dan Junius

(Mr. Daniel Junius)

Currently holds positions in IDEXX Laboratories Inc and GlycoMimetics Inc

Positions
Position Company Period
Independent Director IDEXX Laboratories Inc March 11, 2014 -
Independent Director GlycoMimetics Inc March 17, 2016 -
Independent Director Vitae Pharmaceuticals LLC July 27, 2016 - Oct. 25, 2016
President, Chief Executive Officer, Director ImmunoGen Inc Dec. 30, 2013 - May 16, 2016
President, Chief Executive Officer, Interim Chief Financial Officer, Director ImmunoGen Inc Sept. 13, 2013 - Dec. 30, 2013
President, Chief Executive Officer, Director ImmunoGen Inc Jan. 1, 2009 - Sept. 13, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2023-05-11 2023-05-10
B Purchase
30,000 +47.4%
1.56
46,800 USD
30,000 +47.4% 1.56 46,800 USD
2023-02-17 2023-02-16
S Sale
2,187 -42.3%
511.68
1,119,044 USD
2,187 -42.3% 511.68 1,119,044 USD
2022-12-07 2022-12-05
S Sale
3,046 -50.6%
424.91
1,294,276 USD
3,046 -50.6% 424.91 1,294,276 USD
2022-11-18 2022-11-17
B Purchase
20,000 +46.2%
1.87
37,400 USD
20,000 +46.2% 1.87 37,400 USD
2021-05-24 2021-05-21
S Sale
2,500 -46.4%
539.57
1,348,918 USD
2,500 -46.4% 539.57 1,348,918 USD
2021-02-24 2021-02-22
S Sale
1,888 -39.6%
538.57
1,016,815 USD
1,888 -39.6% 538.57 1,016,815 USD
2021-02-24 2021-02-22
S Sale
10 -0.2%
539.19
5,392 USD
10 -0.2% 539.19 5,392 USD
2020-08-21 2020-08-20
S Sale
3,722 -56.7%
382.61
1,424,063 USD
3,722 -56.7% 382.61 1,424,063 USD
2020-03-10 2020-03-09
B Purchase
20,000 +111.1%
3.40
68,000 USD
20,000 +111.1% 3.40 68,000 USD
2019-08-15 2019-08-13
B Purchase
10,000 +125.0%
3.18
31,800 USD
10,000 +125.0% 3.18 31,800 USD
2016-12-21 2016-12-20
B Purchase
5,000 +inf%
6.01
30,050 USD
5,000 +inf% 6.01 30,050 USD